Shares of vTv Therapeutics Inc. (NASDAQ:VTVT – Get Rating) passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.78 and traded as low as $0.75. vTv Therapeutics shares last traded at $0.79, with a volume of 15,096 shares trading hands. Wall Street Analysts Forecast Growth […]
StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research note released on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $6.00 target price on shares of vTv Therapeutics in a research report on Tuesday, March […]
StockNews.com assumed coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research report report published on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $6.00 target price on shares of vTv Therapeutics in a report on Tuesday, […]
StockNews.com assumed coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $6.00 target price on shares of vTv Therapeutics in a research note […]
StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Rating) in a research report report published on Monday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $6.00 target price on shares of vTv Therapeutics in a report on Tuesday, March […]